Cost-effectiveness of allergen immunotherapy evaluated – Medical Xpress
|
Cost-effectiveness of allergen immunotherapy evaluated
Medical Xpress … the researchers found that sublingual immunotherapy (SLIT) and subcutaneous immunotherapy would be considered cost-effective using the U.K. National Institute for Health and Clinical Excellence threshold of £20,000/quality-adjusted life-year (QALY). |
